HH&L Acquisition Co.
HHLADelisted Feb 23, 2024- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001824185
HH&L Acquisition Co. was delisted on Feb 23, 2024; its insiders filed their last Form 4 on Jan 12, 2024; 19 institutions reported holding it in 13F filings for Q4 2023, worth $40.1M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding HH&L Acquisition Co. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 19 | 17 | −2 |
| Shares | 5.50M | 3.90M | −1.61M (−29.2%) |
| Value | $57.6M | $41.4M | −$16.3M (−28.2%) |
New holders (8)
Institutions that held HH&L Acquisition Co. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Highbridge Capital Management LLC | 600,000 | $6.37M | 0.36% |
| Atlas Merchant Capital LLC | 420,000 | $4.46M | 0.97% |
| Castle Creek Arbitrage, LLC | 403,771 | $4.29M | 1.01% |
| Sandia Investment Management LP | 227,876 | $2.42M | 0.66% |
| Exos TFP Holdings LLC | 201,150 | $2.14M | 1.15% |
| Deutsche Bank AG | 195,909 | $2.08M | 0.00% |
| Tuttle Tactical Management | 15,000 | $159.3K | 1.07% |
| Fifth Lane Capital, LP | 1 | $11 | 0.00% |
Sold out (10)
Institutions that held HH&L Acquisition Co. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Westchester Capital Management, LLC | 831,685 | $8.71M |
| Glazer Capital, LLC | 750,000 | $7.85M |
| Radcliffe Capital Management, L.P. | 500,000 | $5.24M |
| Meteora Capital, LLC | 299,703 | $3.14M |
| Spartan Fund Management Inc. | 282,225 | $2.96M |
| Cubist Systematic Strategies, LLC | 251,922 | $2.64M |
| UBS Oconnor LLC | 162,326 | $1.70M |
| Mint Tower Capital Management B.V. | 140,111 | $1.47M |
| Moore Capital Management, LP | 125,000 | $1.31M |
| K2 Principal Fund, L.P. | 33,948 | $355.4K |